The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Will an App to Monitor Patient Outcomes Improve RA Disease Activity?

Will an App to Monitor Patient Outcomes Improve RA Disease Activity?

July 26, 2021 • By Arthritis & Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Arthritis Power App Can Help Patients Monitor Symptoms, Improve Office Visits
  • How to Leverage Patient-Reported Outcomes to Improve Care for SLE Patients
  • Disease-Activity-Guided TNF Inhibitor Dose Reduction Works Long-Term in RA
Explore This Issue
May 2022

Introduction & Objectives

The majority of patients with rheumatoid arthritis (RA) experience at least one flare in a six-month period. Patients with RA describe these increases in disease activity as emotionally distressing and physically disabling. Prompt reporting of flares to healthcare providers should lead to fast resolution of symptoms and control of overall disease activity. In practice, however, many patients fail to notify their healthcare providers of flares occurring between scheduled appointments. Instead, they try to manage the flares on their own.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Smartphone applications (apps) present a unique opportunity to improve the real-time assessment and management of RA by providing ways to collect electronic patient-reported outcomes (ePROs) between physicians’ appointments, present these data to patients and physicians, and identify sustained increases in these ePROs (i.e., flares) that may benefit from early intervention. At least 17 apps aimed at helping RA patients monitor disease activity are publicly available.

Lee et al. examined the effects of using an app to monitor longitudinal ePROs on patient satisfaction and disease activity in patients with RA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Methods

The researchers conducted a six-month randomized controlled trial of care coordination along with an app (intervention) vs. care coordination alone (control) in 191 RA patients. Participants in the intervention group were prompted to provide information daily using ePROs. In both the intervention and control groups, a care coordinator contacted participants at 6 and 18 weeks to assess for flares. The main outcome measures were the global satisfaction score from the Treatment Satisfaction Questionnaire for Medication (TSQM), the score from the Perceived Efficacy in Patient-Physician Interactions (PEPPI) Questionnaire and the Clinical Disease Activity Index (CDAI) score.

Results

Groups were similar at baseline. The median TSQM score at six months was 83.3 in both groups, and the median PEPPI score at six months was 50 in both groups. The median CDAI score at six months was 8 in the intervention group versus 10 in the control group. No statistically significant group differences in the medians of TSQM, PEPPI, or CDAI scores at six months were detected. Of the 67 intervention participants who completed the exit survey, 90% rated their likelihood of recommending the app as seven or greater on a 10-point scale. Of the 11 physicians who completed the exit survey, 73% agreed or strongly agreed that they wanted to continue offering the app to patients.

Conclusion

A mobile app designed to collect ePRO data on RA symptoms did not significantly improve patient satisfaction or disease activity compared to care coordination alone. However, both patients and physicians reported positive experiences with the app.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Apps, Conditions, Rheumatoid Arthritis, Technology Tagged With: Arthritis & Rheumatology, patient outcomes, Rheumatoid Arthritis (RA), smartphone, Smartphone app, TechnologyIssue: May 2022

You Might Also Like:
  • Arthritis Power App Can Help Patients Monitor Symptoms, Improve Office Visits
  • How to Leverage Patient-Reported Outcomes to Improve Care for SLE Patients
  • Disease-Activity-Guided TNF Inhibitor Dose Reduction Works Long-Term in RA
  • RA Choice: A Tool to Improve Patient Literacy

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)